Energy News / Shareholders Foundation, Inc.

NASDAQ:ELOX Shareholder Alert: Investigation over Potential Wrongdoing at Eloxx Pharmaceuticals, Inc.

Via: ReleaseWire

Updated 12:00 PM CDT, Fri, May 31,2019

An investigation on behalf of investors in Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) shares over potential wrongdoing at Eloxx Pharmaceuticals, Inc. was announced.

San Diego, CA -- (SBWIRE) -- 05/31/2019 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Eloxx Pharmaceuticals, Inc.

Investors who purchased shares of Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Eloxx Pharmaceuticals directors breached their fiduciary duties and caused damage to the company and its shareholders.

Waltham, MA based Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops novel ribonucleic acid for the treatment of rare and ultra-rare premature stop codon diseases. Shares of Eloxx Pharmaceuticals, Inc. (NASDAQ" ELOX) declined from $24.90 per share on June 15, 2019 to as low as $9.01 per share on May 29, 2019.

Those who purchased shares of Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaqelox-shareholder-alert-investigation-over-potential-wrongdoing-at-eloxx-pharmaceuticals-inc-1227421.htm

Media Relations Contact
Michael Daniels
1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com